{"id":17517,"date":"2025-11-11T14:35:30","date_gmt":"2025-11-11T14:35:30","guid":{"rendered":"https:\/\/lite14.net\/blog\/?p=17517"},"modified":"2025-11-11T14:35:30","modified_gmt":"2025-11-11T14:35:30","slug":"gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2","status":"publish","type":"post","link":"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/","title":{"rendered":"GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report"},"content":{"rendered":"<p>&nbsp;<\/p>\n<hr \/>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#What_the_report_is\" >What the report is<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#What_was_found_ranking_highlights\" >What was found &amp; ranking highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#Why_this_matters\" >Why this matters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#Key_observations_comments\" >Key observations &amp; comments<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#Things_to_watch_open_questions\" >Things to watch &amp; open questions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#Case_Study%E2%80%AF1_GSK_GlaxoSmithKline\" >Case Study\u202f1: GSK (GlaxoSmithKline)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#Case_Study%E2%80%AF2_Amgen\" >Case Study\u202f2: Amgen<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#Case_Study%E2%80%AF3_AstraZeneca\" >Case Study\u202f3: AstraZeneca<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#Broader_Commentary_Implications\" >Broader Commentary &amp; Implications<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_the_report_is\"><\/span>What the report is<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>This is the <strong>5th\u202fAnnual<\/strong> edition of the \u201cTGaS Digital Marketing Competency Report\u201d by Trinity Life Sciences \u2014 the 2025 edition covers more than 150 biopharma brands. (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<li>The methodology: Brands are ranked on a scale from <strong>\u201cTransformational\u201d<\/strong> to \u201cNovice\u201d, evaluated across <strong>100+ characteristics<\/strong> spanning omnichannel presence, patient\u2011centricity, digital execution (e.g., website, search, social, direct\u2011to\u2011consumer access). (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<li>Key metrics in this edition: A 19\u202f% increase in brands reaching \u201cProficient\u201d status compared to prior years; a 112\u202f% increase in brands integrating <strong>Reddit<\/strong> into their social approach (signalling shift away from just Facebook\/Instagram) among other digital innovations. (<a title=\"Trinity\u2019s 2025 Report Redefines Biopharma Digital Marketing Excellence\" href=\"https:\/\/ciobulletin.com\/digital-marketing\/trinity-report-biopharma-digital-marketing?utm_source=chatgpt.com\">ciobulletin.com<\/a>)<\/li>\n<li>The report also highlights stronger Direct\u2011to\u2011Consumer (DTC) access strategies emerging in life sciences \u2014 i.e., manufacturers engaging directly with patients\/caregivers rather than purely through HCP or payer channels. (<a title=\"GSK, Amgen and AstraZeneca Lead the Pack in Trinity\u2019s 2025 Digital Marketing Competency Report\" href=\"https:\/\/finance.yahoo.com\/news\/gsk-amgen-astrazeneca-lead-pack-130000584.html?utm_source=chatgpt.com\">Yahoo Finance<\/a>)<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"What_was_found_ranking_highlights\"><\/span>What was found &amp; ranking highlights<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The companies named in the headline \u2014 GSK, Amgen and AstraZeneca \u2014 are highlighted as <strong>leaders<\/strong> in this 2025 ranking. (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<li>Specific brands recognised as \u201cTransformational\u201d in the report include:\n<ul>\n<li>Trelegy (GSK)<\/li>\n<li>Arexvy (GSK)<\/li>\n<li>Tezspire (Amgen &amp; AstraZeneca)<\/li>\n<li>Hemlibra (Genentech)<\/li>\n<li>Mavyret (AbbVie) (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<\/ul>\n<\/li>\n<li>Additional top\u2010level insights:\n<ul>\n<li>The \u201cProficient\u201d category (middle\u2011high of maturity) saw a 19\u202f% uplift vs previous year \u2014 indicating increasing digital maturity across the industry. (<a title=\"2025 Digital Marketing Competency Report for Biopharma\" href=\"https:\/\/trinitylifesciences.com\/briefs\/2024-annual-digital-marketing-competency-report\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<li>Social channel diversification: The 112\u202f% rise in Reddit use suggests pharma brands are exploring community\u2010driven, niche social channels. (<a title=\"Trinity\u2019s 2025 Report Redefines Biopharma Digital Marketing Excellence\" href=\"https:\/\/ciobulletin.com\/digital-marketing\/trinity-report-biopharma-digital-marketing?utm_source=chatgpt.com\">ciobulletin.com<\/a>)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Why_this_matters\"><\/span>Why this matters<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>For marketers in life sciences<\/strong>: The study provides a benchmark of where brands stand digitally, and shows they can no longer treat digital as \u201cadjunct\u201d \u2014 omnichannel and patient\u2011centric digital engagement is now a core commercial competency.<\/li>\n<li><strong>For the named companies<\/strong>:\n<ul>\n<li>GSK, Amgen &amp; AstraZeneca being flagged as leaders gives them a competitive narrative (digital first, patient engagement) that can support investor perception, brand differentiation, and internal stakeholder alignment.<\/li>\n<li>For them this recognition may translate into pressure to maintain or accelerate digital innovation lest they fall behind.<\/li>\n<\/ul>\n<\/li>\n<li><strong>For the broader industry<\/strong>:\n<ul>\n<li>The average improvement (19\u202f% increase) indicates the sector is moving forward \u2014 but also raises the bar: if you\u2019re a brand still in \u201cNovice\u201d or \u201cEmerging\u201d you risk being left behind.<\/li>\n<li>The shift to direct\u2011to\u2011consumer and newer channels (like Reddit) signals a potential change in how pharma reaches patients \u2013 more peer\/community, less classic top\u2011down marketing. This has implications for compliance\/regulation, data governance and commercial model change.<\/li>\n<\/ul>\n<\/li>\n<li><strong>For agencies &amp; suppliers<\/strong>: These trends highlight demand for digital capability (SEO, social beyond the usual, community building, omnichannel orchestration) and may drive service demand in life sciences marketing.<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Key_observations_comments\"><\/span>Key observations &amp; comments<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The fact that Reddit has become a highlighted channel (112\u202f% increase) suggests brands recognise that <em>where patients and caregivers are congregating online<\/em> is shifting \u2014 less broadcast, more community. That invites risk &amp; reward: the risk of moderation, compliance, off\u2011label discussion; the reward of deeper engagement.<\/li>\n<li>The \u201cProficient\u201d category\u2019s growth (19\u202f%) is good, but the report still implicitly suggests many brands remain in lower maturity levels. In other words: leadership is becoming differentiated, not average.<\/li>\n<li>The emphasis on \u201cpatient\u2011centricity\u201d and \u201cdigital execution\u201d rather than purely \u201cdigital marketing\u201d signals the pivot in life sciences: from promotion of a drug \u2192 to experience \/ engagement over the patient lifecycle.<\/li>\n<li>For GSK, Amgen and AstraZeneca: this recognition may attract talent (digital marketers want to work for \u201ctransformational\u201d companies), perhaps ease internal change management, but also sets expectations for delivery \u2014 i.e., \u2018you\u2019ve won recognition, now you must keep innovating\u2019.<\/li>\n<li>The mention of Direct\u2011to\u2011Consumer (DTC) access is interesting \u2014 life sciences has typically been channelled through HCPs, payers and institutions. A shift to more DTC might raise strategic \/ regulatory issues \u2014 e.g., how to manage data, privacy, consent, continual engagement rather than episodic intervention.<\/li>\n<li>From a commercial strategy perspective: Digital competency becomes a <strong>competitive differentiator<\/strong>. If Brand\u202fA has high digital engagement and Brand\u202fB doesn\u2019t, Brand\u202fA may gain advantage in launch, patient uptake, adherence and brand loyalty.<\/li>\n<li>For investors \/ analysts: This kind of ranking and the underlying shift signal that companies investing in digital capability may achieve better commercial outcomes and perhaps pricing\/premium.<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Things_to_watch_open_questions\"><\/span>Things to watch &amp; open questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>What are the <strong>metrics<\/strong> behind \u201cTransformational\u201d vs \u201cProficient\u201d vs \u201cNovice\u201d? The methodology summary shows more than 100 criteria, but brands may differ in how they achieve them (e.g., social innovation vs website\/SEO vs omnichannel orchestration). (<a title=\"An excerpt from the full report\" href=\"https:\/\/trinitylifesciences.com\/wp-content\/uploads\/2021\/11\/TGaS-Advisors-2021-Digital-Competency-Report.pdf?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<li>Will this lead to <strong>budget shifts<\/strong>? If digital sophistication is rewarded, will we see more spend diverted from traditional channels to emerging digital\/patient\u2011community channels?<\/li>\n<li>Will regulatory frameworks (especially outside the U.S.) adapt to this shift? Digital engagement, DTC access, social community work may face compliance scrutiny.<\/li>\n<li>What is the <strong>return on investment<\/strong> for brands flagged as \u201cTransformational\u201d? Are they achieving better launch uptake, higher patient retention, improved adherence, lower cost per patient? The report hints at these but the public summary doesn\u2019t show full ROI data.<\/li>\n<li>Are smaller or niche brands able to catch up, or is the gap widening between digital \u201chaves\u201d and \u201chave\u2011nots\u201d? The 19\u202f% uplift is good, but absolute maturity may still be far off for many brands.<\/li>\n<li>Here are three detailed <strong>case studies<\/strong> of how Trinity Life Sciences\u2019s \u201c5th Annual TGaS Digital Marketing Competency Report\u201d (2025) highlights digital marketing excellence within the pharma\/biotech sector \u2014 focusing on GlaxoSmithKline (GSK), Amgen Inc. and AstraZeneca PLC \u2014 followed by broader commentary and implications.<br \/>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Case_Study%E2%80%AF1_GSK_GlaxoSmithKline\"><\/span>Case Study\u202f1: GSK (GlaxoSmithKline)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Background &amp; ranking<\/strong><\/p>\n<ul>\n<li>GSK is recognised as one of the top\u2011performing companies in the 2025 report, with its brands like Trelegy and Arexvy being cited among the \u201cTransformational\u201d digital marketing brands. (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<li>The report shows the overall \u201cProficient\u201d tier of brands increased by 19%, indicating GSK is part of the advancing cohort. (<a title=\"2025 Digital Marketing Competency Report for Biopharma\" href=\"https:\/\/trinitylifesciences.com\/briefs\/2024-annual-digital-marketing-competency-report\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<\/ul>\n<p><strong>Key digital strategy highlights<\/strong><\/p>\n<ul>\n<li>Focus on patient\u2011centric digital engagement: Rather than only promoting awareness, GSK\u2019s listed brands demonstrate deeper digital journeys (e.g., patient portals, digital resources, community hubs) as per the report\u2019s patient\u2011centricity criteria.<\/li>\n<li>Use of omnichannel execution: The report evaluates \u201comnichannel presence, patient\u2011centricity, digital execution (100+ characteristics)\u201d. GSK\u2019s inclusion among top brands suggests strong performance across multiple channels (website, search\/SEO, social, direct\u2011to\u2011consumer access) rather than isolated tactics. (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<li>Innovation in channel strategy: The report cites a <strong>112\u202f% increase<\/strong> in use of Reddit by brands (i.e., moving beyond Facebook\/Instagram) as a hallmark of digital maturity. GSK, as a top performer, is likely among those adopting newer channels. (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<\/ul>\n<p><strong>Why this matters<\/strong><\/p>\n<ul>\n<li>For GSK, achieving a \u201cTransformational\u201d rating gives a competitive advantage \u2014 internally (marketing teams can flag digital\u2011excellence) and externally (investors and stakeholders can view GSK as a digital frontrunner).<\/li>\n<li>It signals that GSK is likely better placed than many peers to navigate the evolving digital ecosystem (patient\u2011community engagement, DTC access, omnichannel measurement).<\/li>\n<li>From a commercial launch perspective, strong digital marketing maturity may accelerate uptake of new products, reinforce patient adherence, and boost brand loyalty.<\/li>\n<\/ul>\n<p><strong>Challenges \/ considerations<\/strong><\/p>\n<ul>\n<li>Maintaining the lead: When you\u2019re flagged as a top performer, expectation rises \u2014 digital execution must keep evolving. GSK must ensure its digital infrastructure, data capabilities, and measurement frameworks scale accordingly.<\/li>\n<li>Regulatory &amp; compliance risk: With deeper patient engagement and more direct\u2011to\u2011consumer strategies (highlighted in the report), GSK must ensure adherence to privacy, health\u2011claims and data governance.<\/li>\n<li>Competitive pressure: As other brands increase maturity (19% lift in Proficient brands), the \u201clead\u201d may narrow \u2014 GSK must continue innovating, not just maintain status quo.<\/li>\n<\/ul>\n<p><strong>Key takeaway<\/strong><br \/>\nGSK\u2019s strong showing in the 2025 TGaS report demonstrates that the company is well advanced in digital marketing maturity. For marketers, it sets a benchmark: it\u2019s not enough to just have digital channels \u2014 it\u2019s about integrated, patient\u2011centric journeys and newer forms of engagement.<\/p>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Case_Study%E2%80%AF2_Amgen\"><\/span>Case Study\u202f2: Amgen<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Background &amp; ranking<\/strong><\/p>\n<ul>\n<li>Amgen is one of the three companies named in the headline as \u201cleading the pack\u201d in the 2025 report. (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<li>Its brand partnership with AstraZeneca (for example the medication Tezspire) is cited as a \u201cTransformational\u201d brand in 2025. (<a title=\"GSK, Amgen and AstraZeneca Lead the Pack in Trinity\u2019s 2025 Digital Marketing Competency Report\" href=\"https:\/\/finance.yahoo.com\/news\/gsk-amgen-astrazeneca-lead-pack-130000584.html?utm_source=chatgpt.com\">Yahoo Finance<\/a>)<\/li>\n<\/ul>\n<p><strong>Key digital strategy highlights<\/strong><\/p>\n<ul>\n<li>Collaboration\/partnership digital model: By partnering with AstraZeneca on Tezspire, Amgen demonstrates that digital marketing excellence can be a joint effort \u2014 especially when products span companies. This may include shared digital assets, co\u2011branded patient engagement platforms, etc.<\/li>\n<li>Direct\u2011to\u2011Consumer (DTC) access exploration: The report states leading brands are exploring DTC access strategies. As a leading brand, Amgen likely has initiatives to more directly engage patients\/caregivers rather than rely solely on HCP channels. (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<li>Channel innovation: The report emphasises expansion beyond \u201ctraditional platforms\u201d (e.g., using Reddit, niche communities) \u2014 Amgen\u2019s inclusion at the top suggests it is executing in those areas.<\/li>\n<\/ul>\n<p><strong>Why this matters<\/strong><\/p>\n<ul>\n<li>Amgen\u2019s digital maturity gives it advantage in launching, scaling and sustaining new therapies in a competitive market. With digital sophistication, Amgen can better meet changing patient expectations (more self\u2011service, community support, digital ecosystems).<\/li>\n<li>The partnership model (with AstraZeneca) shows that digital marketing excellence is not just company\u2011centric; it may be collaborative across companies and brands, especially in complex therapeutic areas.<\/li>\n<\/ul>\n<p><strong>Challenges \/ considerations<\/strong><\/p>\n<ul>\n<li>Coordinating across organisations: When collaborating (Amgen + AstraZeneca), aligning digital strategy, measurement, brand governance and data systems can be complex.<\/li>\n<li>Scale of digital expectations: As Amgen is recognised among digital leaders, there\u2019s expectation for consistent innovation \u2014 digital fatigue or under\u2011investment may erode advantage.<\/li>\n<li>Ensuring differentiation: With many brands improving (19% uplift in Proficient tier), Amgen must avoid complacency and keep differentiating its digital engagement model.<\/li>\n<\/ul>\n<p><strong>Key takeaway<\/strong><br \/>\nAmgen\u2019s recognition in the 2025 TGaS report shows the company is a benchmark for digital marketing maturity in life sciences \u2014 particularly in how it leverages partnerships, direct patient engagement and next\u2011gen channels.<\/p>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Case_Study%E2%80%AF3_AstraZeneca\"><\/span>Case Study\u202f3: AstraZeneca<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Background &amp; ranking<\/strong><\/p>\n<ul>\n<li>AstraZeneca is also named in the 2025 report as a leading digital marketer. (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<\/li>\n<li>The brand Tezspire (Amgen &amp; AstraZeneca) is cited as Transformational. Additionally, AstraZeneca\u2019s prior performance (e.g., Breztri in 2024) highlights consistent digital excellence. (<a title=\"Pfizer\u2019s Nurtec and Astrazeneca\u2019s Breztri Share Top Ranking in 2024 Digital Marketing Competency Report\" href=\"https:\/\/www.bastillepost.com\/global\/article\/4384733-pfizers-nurtec-and-astrazenecas-breztri-share-top-ranking-in-2024-digital-marketing-competency-report?utm_source=chatgpt.com\">Bastille Post<\/a>)<\/li>\n<\/ul>\n<p><strong>Key digital strategy highlights<\/strong><\/p>\n<ul>\n<li>Consistent digital positioning: AstraZeneca has been appearing at the top of these rankings for multiple years, suggesting maturity not just in isolated campaigns but in the entire digital strategy.<\/li>\n<li>Patient\u2011centric, omni\u2011channel approach: With focus on patient experience, AstraZeneca\u2019s digital strategy likely includes multi\u2011channel touchpoints, digital ecosystems, community engagement and measurement.<\/li>\n<li>Use of new channels\/community platforms: The report highlights a 112% increase in Reddit usage among brands; AstraZeneca being among leaders implies it is adopting such platforms. (<a title=\"Trinity\u2019s 2025 Report Redefines Biopharma Digital Marketing Excellence\" href=\"https:\/\/ciobulletin.com\/digital-marketing\/trinity-report-biopharma-digital-marketing?utm_source=chatgpt.com\">ciobulletin.com<\/a>)<\/li>\n<\/ul>\n<p><strong>Why this matters<\/strong><\/p>\n<ul>\n<li>For AstraZeneca, being digitally advanced reinforces brand reputation as innovative \u2014 both in therapy and in engagement models. This can enhance launch success, patient adherence and brand loyalty.<\/li>\n<li>Their digital traction may help them better respond to market changes: patient expectations for digital services, virtual support, online communities etc.<\/li>\n<\/ul>\n<p><strong>Challenges \/ considerations<\/strong><\/p>\n<ul>\n<li>Structural scale: Large global companies like AstraZeneca must ensure local market (regional) execution matches global strategy \u2014 digital maturity needs regional adaptation.<\/li>\n<li>Emerging channel risk: As brands pivot to new platforms (Reddit, community forums), they must monitor data\/privacy\/regulatory risk.<\/li>\n<li>Staying ahead: With many brands catching up (industry\u2011wide improvement), AstraZeneca must continue to innovate rather than rest on laurels.<\/li>\n<\/ul>\n<p><strong>Key takeaway<\/strong><br \/>\nAstraZeneca\u2019s consistent high ranking in the TGaS report signals digital marketing leadership in life sciences. The company sets the bar for how digital patient experience and omnichannel engagement can be leveraged in pharma.<\/p>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Broader_Commentary_Implications\"><\/span>Broader Commentary &amp; Implications<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>1. The digital maturity gap is shrinking, but leaders remain distinct.<\/strong><br \/>\nThe 2025 report shows a 19% uplift in brands achieving \u201cProficient\u201d rating \u2014 meaning many companies have improved. But the \u201cTransformational\u201d tier (where GSK, Amgen, AstraZeneca sit) remains differentiated. (<a title=\"Trinity\u2019s 2025 Report Redefines Biopharma Digital Marketing Excellence\" href=\"https:\/\/ciobulletin.com\/digital-marketing\/trinity-report-biopharma-digital-marketing?utm_source=chatgpt.com\">ciobulletin.com<\/a>)<br \/>\nThis means: even as more companies catch up, being a digital leader still offers competitive advantage.<\/p>\n<p><strong>2. Patient\u2011centric engagement and DTC access are non\u2011negotiable.<\/strong><br \/>\nThe report emphasises the shift: brands are moving beyond treatment awareness to long\u2011term patient relationships (wellness, digital support, behavioral change). DTC models are gaining traction. (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<br \/>\nFor companies, this means investment in digital ecosystems, data platforms, and new KPIs (not just \u201cimpressions\u201d or \u201cHCP reach\u201d).<\/p>\n<p><strong>3. Platform diversification is critical.<\/strong><br \/>\nThe 112% increase in Reddit usage indicates a move beyond Facebook\/Instagram into community\u2011led and niche forums. (<a title=\"2025 Digital Marketing Report: Biopharma Brand Rankings\" href=\"https:\/\/trinitylifesciences.com\/company\/press-releases\/gsk-amgen-and-astrazeneca-in-2025-dmcr\/?utm_source=chatgpt.com\">Trinity Life Sciences<\/a>)<br \/>\nImplication: digital strategies must account for emerging channels, moderation, community management and measurement.<\/p>\n<p><strong>4. Collaboration &amp; co\u2011brands matter.<\/strong><br \/>\nAmgen &amp; AstraZeneca\u2019s joint brand success (Tezspire) shows that digital marketing excellence can cross organisational boundaries. Partnerships in digital (co\u2011branded platforms, shared ecosystems) are increasingly viable.<\/p>\n<p><strong>5. For marketers and agencies:<\/strong><\/p>\n<ul>\n<li>Benchmarking (like this TGaS report) is essential \u2014 you need to know where you stand.<\/li>\n<li>Investing in infrastructure (data, CRM, measurement), ecosystem (patient portals, community forums), and content is key.<\/li>\n<li>Capacity building: Smaller brands may struggle to catch up without dedicated digital capability.<\/li>\n<\/ul>\n<p><strong>6. For investors \/ executives:<\/strong><br \/>\nDigital marketing maturity may correlate with better launch execution, stronger patient adherence, and competitive advantage \u2014 thus digital capability is increasingly a strategic asset, not just a marketing cost centre.<\/p>\n<p><strong>7. Risks \/ Watch\u2011outs:<\/strong><\/p>\n<ul>\n<li>Regulatory \/ privacy risk: As brands engage directly with patients and new channels, regulatory frameworks (especially for pharma) must be navigated carefully.<\/li>\n<li>ROI measurement: The report shows progress, but it doesn\u2019t publicly provide detailed ROI data \u2014 brands must ensure they can link digital engagement to commercial outcomes.<\/li>\n<li>Saturation \/ diminishing returns: As more brands become proficient, standing out may become harder; innovation remains essential.<\/li>\n<\/ul>\n<hr \/>\n<p>&nbsp;<\/li>\n<\/ul>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; What the report is This is the 5th\u202fAnnual edition of the \u201cTGaS Digital Marketing Competency Report\u201d by Trinity Life Sciences \u2014 the 2025 edition&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[270,90],"tags":[],"class_list":["post-17517","post","type-post","status-publish","format-standard","hentry","category-digital-marketing","category-news-update"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report - Lite14 Tools &amp; Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report - Lite14 Tools &amp; Blog\" \/>\n<meta property=\"og:description\" content=\"&nbsp; What the report is This is the 5th\u202fAnnual edition of the \u201cTGaS Digital Marketing Competency Report\u201d by Trinity Life Sciences \u2014 the 2025 edition...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Lite14 Tools &amp; Blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-11T14:35:30+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/lite14.net\/blog\/#\/schema\/person\/551c62581e407fcec8cf1f76df97b5d2\"},\"headline\":\"GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report\",\"datePublished\":\"2025-11-11T14:35:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/\"},\"wordCount\":2240,\"publisher\":{\"@id\":\"https:\/\/lite14.net\/blog\/#organization\"},\"articleSection\":[\"Digital Marketing\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/\",\"url\":\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/\",\"name\":\"GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report - Lite14 Tools &amp; Blog\",\"isPartOf\":{\"@id\":\"https:\/\/lite14.net\/blog\/#website\"},\"datePublished\":\"2025-11-11T14:35:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lite14.net\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lite14.net\/blog\/#website\",\"url\":\"https:\/\/lite14.net\/blog\/\",\"name\":\"Lite14 Tools &amp; Blog\",\"description\":\"Email Marketing Tools &amp; Digital Marketing Updates\",\"publisher\":{\"@id\":\"https:\/\/lite14.net\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lite14.net\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/lite14.net\/blog\/#organization\",\"name\":\"Lite14 Tools &amp; Blog\",\"url\":\"https:\/\/lite14.net\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lite14.net\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lite14.net\/blog\/wp-content\/uploads\/2025\/09\/cropped-lite-logo.png\",\"contentUrl\":\"https:\/\/lite14.net\/blog\/wp-content\/uploads\/2025\/09\/cropped-lite-logo.png\",\"width\":191,\"height\":178,\"caption\":\"Lite14 Tools &amp; Blog\"},\"image\":{\"@id\":\"https:\/\/lite14.net\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/lite14.net\/blog\/#\/schema\/person\/551c62581e407fcec8cf1f76df97b5d2\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lite14.net\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/37de671670ea9023731c3f3ef83c84b6d7d6faeffecd87fb98e3ec10aecc15bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/37de671670ea9023731c3f3ef83c84b6d7d6faeffecd87fb98e3ec10aecc15bd?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"http:\/\/lite14.net\/blog\"],\"url\":\"https:\/\/lite14.net\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report - Lite14 Tools &amp; Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/","og_locale":"en_US","og_type":"article","og_title":"GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report - Lite14 Tools &amp; Blog","og_description":"&nbsp; What the report is This is the 5th\u202fAnnual edition of the \u201cTGaS Digital Marketing Competency Report\u201d by Trinity Life Sciences \u2014 the 2025 edition...","og_url":"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/","og_site_name":"Lite14 Tools &amp; Blog","article_published_time":"2025-11-11T14:35:30+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#article","isPartOf":{"@id":"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/"},"author":{"name":"admin","@id":"https:\/\/lite14.net\/blog\/#\/schema\/person\/551c62581e407fcec8cf1f76df97b5d2"},"headline":"GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report","datePublished":"2025-11-11T14:35:30+00:00","mainEntityOfPage":{"@id":"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/"},"wordCount":2240,"publisher":{"@id":"https:\/\/lite14.net\/blog\/#organization"},"articleSection":["Digital Marketing","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/","url":"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/","name":"GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report - Lite14 Tools &amp; Blog","isPartOf":{"@id":"https:\/\/lite14.net\/blog\/#website"},"datePublished":"2025-11-11T14:35:30+00:00","breadcrumb":{"@id":"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/lite14.net\/blog\/2025\/11\/11\/gsk-amgen-and-astrazeneca-top-trinitys-latest-digital-marketing-competency-report-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lite14.net\/blog\/"},{"@type":"ListItem","position":2,"name":"GSK, Amgen, and AstraZeneca Top Trinity\u2019s Latest Digital Marketing Competency Report"}]},{"@type":"WebSite","@id":"https:\/\/lite14.net\/blog\/#website","url":"https:\/\/lite14.net\/blog\/","name":"Lite14 Tools &amp; Blog","description":"Email Marketing Tools &amp; Digital Marketing Updates","publisher":{"@id":"https:\/\/lite14.net\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lite14.net\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/lite14.net\/blog\/#organization","name":"Lite14 Tools &amp; Blog","url":"https:\/\/lite14.net\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lite14.net\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/lite14.net\/blog\/wp-content\/uploads\/2025\/09\/cropped-lite-logo.png","contentUrl":"https:\/\/lite14.net\/blog\/wp-content\/uploads\/2025\/09\/cropped-lite-logo.png","width":191,"height":178,"caption":"Lite14 Tools &amp; Blog"},"image":{"@id":"https:\/\/lite14.net\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/lite14.net\/blog\/#\/schema\/person\/551c62581e407fcec8cf1f76df97b5d2","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lite14.net\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/37de671670ea9023731c3f3ef83c84b6d7d6faeffecd87fb98e3ec10aecc15bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/37de671670ea9023731c3f3ef83c84b6d7d6faeffecd87fb98e3ec10aecc15bd?s=96&d=mm&r=g","caption":"admin"},"sameAs":["http:\/\/lite14.net\/blog"],"url":"https:\/\/lite14.net\/blog\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/lite14.net\/blog\/wp-json\/wp\/v2\/posts\/17517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lite14.net\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lite14.net\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lite14.net\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lite14.net\/blog\/wp-json\/wp\/v2\/comments?post=17517"}],"version-history":[{"count":1,"href":"https:\/\/lite14.net\/blog\/wp-json\/wp\/v2\/posts\/17517\/revisions"}],"predecessor-version":[{"id":17518,"href":"https:\/\/lite14.net\/blog\/wp-json\/wp\/v2\/posts\/17517\/revisions\/17518"}],"wp:attachment":[{"href":"https:\/\/lite14.net\/blog\/wp-json\/wp\/v2\/media?parent=17517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lite14.net\/blog\/wp-json\/wp\/v2\/categories?post=17517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lite14.net\/blog\/wp-json\/wp\/v2\/tags?post=17517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}